# OnCo record paper-overman-checkmate-142-nivolumab-dmmr-colorectal-lancet-oncol-2017 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: .
@prefix onco: .
@prefix xsd: .
a schema:ScholarlyArticle ;
onco:kind "paper" ;
schema:identifier "paper-overman-checkmate-142-nivolumab-dmmr-colorectal-lancet-oncol-2017" ;
schema:name "Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142)"@en ;
schema:description "Seventy-four heavily pre-treated patients whose bowel cancers had lost DNA mismatch repair were given nivolumab; nearly a third responded and most of those responses were still going a year later."@en ;
schema:url ;
schema:dateModified "2026-09-24"^^xsd:date ;
schema:citation , ;
schema:sameAs ;
schema:datePublished "2017"^^xsd:gYear ;
schema:author "Overman MJ, McDermott R, Leach JL, et al." ;
onco:related , ;
onco:cancers ;
onco:technologies , ;
onco:targets , ;
onco:drugs ;
onco:institutions ;
onco:pathways , ;
onco:terms , ;
onco:trials ;
onco:people , ;
onco:journals .